UBD and pachyonychia congenita: In vivo and in vitro experiments revealed that reducing the expression of FAT10 inhibits the proliferation of PC cells, makes them more sensitive to GEM treatment, and promotes PC cell apoptosis, thereby indicating that FAT10 may serve as a biomarker of the chemotherapeutic sensitivity of PC.